Concepedia

Martin Siegemund

MS

9

Publications

431

Citations

9

H-Index

2011

Active since

Affiliations

University of Stuttgart(Current)

Technische Universität Dresden

University of Tübingen

Medizinische Hochschule Hannover

Martin Siegemund is an author at University of Stuttgart specializing in protein engineering, tumor biology, and antibody engineering.

ORCID

Top concepts

Publications per year

2011–2018

9

Publications

9

A TNF Receptor 2 Selective Agonist Rescues Human Neurons from Oxidative Stress-Induced Cell Death

Roman Fischer, Olaf Maier, Martin Siegemund et al. · PLoS ONE · 2011 · 122 citations · Full text

Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity

Martin Siegemund, Nadine Pollak, Oliver Seifert et al. · Cell Death and Disease · 2012 · 67 citations · Full text

Increased Apoptosis Induction in Hepatocellular Carcinoma by a Novel Tumor-Targeted TRAIL Fusion Protein Combined With Bortezomib

Kristin Wahl, Martin Siegemund, Frank Lehner et al. · Hepatology · 2012 · 48 citations

Tetravalent Antibody–scTRAIL Fusion Proteins with Improved Properties

Oliver Seifert, Aline Plappert, Sina Fellermeier et al. · Molecular Cancer Therapeutics · 2013 · 42 citations

, , +12

Superior Properties of Fc-comprising scTRAIL Fusion Proteins

Meike Hutt, Lisa Marquardt, Oliver Seifert et al. · Molecular Cancer Therapeutics · 2017 · 38 citations

Rows per page

1–5 of 9